Skip to content
GLP-1 Scorecard
Menu
Graded #487

VevaRX

VevaRX publishes four prices for semaglutide on one page, two of which belong to tirzepatide, and gets its own per-month arithmetic wrong in the process.

Visit VevaRXWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$189/mo (the same page also prints $167 a month and $467 for three months)
Tirzepatide
$467 per three months, auto-renewing (about $155.67 a month; no monthly option is offered)
Coverage
36 states
Brand-name
Compounded only

Weigh VevaRX against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because VevaRX dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value35/100
Dose & formulation64/100
Clinical oversight66/100
Labs & monitoring62/100
Fulfillment75/100
Contract terms20/100

Strengths

  • Publishes an exact 36-state list by name rather than a nationwide claim it then hedges
  • States what the three-month figure covers — medication, supplies and the provider visit — and includes free two- to three-day shipping
  • Unlimited physician access and a 24/7 care team are described as inside the program price
  • Prices its peptide products openly beside the GLP-1 lines

Where it loses points

  • Tirzepatide has no monthly option: it is sold as $467 for three months on a quarterly auto-renewal with a three-month minimum
  • The tirzepatide page's own arithmetic is wrong — it calls $467 equivalent to $149 a month when the figure is $155.67, which the semaglutide page states correctly
  • The semaglutide page carries four prices, two of which belong to tirzepatide
  • Follow-up consultations are priced separately at $299 and $399, which the program pages do not mention
  • NAD+ is priced three different ways on one page, at $399, $447 and $267
  • Another company's domain appears in VevaRX's own Terms, in the transaction currency clause
  • The contact page FAQ is a different product's copy and gives dosing instructions for a powdered drink under the question of how to take semaglutide or tirzepatide
  • Two opposite return policies are live, and no pharmacy, compounding class, clinician or medical group is named anywhere

Bottom line — Grade C

Best for: Readers in its 36 states who want a three-month program and will confirm every figure with support before paying.

Ranked #487 of 536 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest VevaRX — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect VevaRX's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on VevaRX's site. Not medical advice; see our disclosure.

← Back to the scorecard